Fibroblasts and Skin Aging

Fibroblasts are the cells in the dermis responsible for producing and maintaining collagen, elastin, and the extracellular matrix that give skin its strength, thickness, and firmness. But fibroblasts age too. Over time, UV exposure, oxidative stress, DNA damage, telomere shortening, mitochondrial dysfunction, impaired autophagy and lysosomal function, loss of proteostasis, epigenetic changes, and cellular senescence can interfere with their ability to function normally. Aging fibroblasts produce and organize the extracellular matrix less effectively, while senescent fibroblasts can release inflammatory and collagen-degrading signals that further accelerate skin aging. Understanding why fibroblasts age helps explain many of the changes we see in aging skin, including wrinkles, sagging, thinning, and loss of resilience. This article will look at the major cellular processes that cause fibroblasts to age and lose their ability to keep skin healthy and strong.

In young skin, fibroblasts are stretched out and connected to structural proteins in the extracellular matrix (ECM). Think of the fibroblast as the center of a trampoline, held in place by many tiny “strings” connecting it to the surrounding ECM. When these strings pull on the fibroblast, the cell feels this tension, which triggers signals that tell it to perform important functions, including making collagen. The receptors that connect the fibroblast to the ECM and sense these mechanical forces are called integrins.
As we age, structural proteins in the ECM become damaged and fragmented, and some of these connections are lost. Like a trampoline with loose or broken strings, the fibroblast loses tension and becomes smaller, rounder, and more collapsed. Without normal mechanical tension, collagen-producing signals decrease and the fibroblast makes less collagen.

Fibroblasts make collagen through a complex process that begins with collagen gene transcription, followed by production of procollagen chains, their modification and assembly into a stable triple helix, secretion from the cell, and formation of collagen fibrils in the extracellular matrix.

With age, several parts of this process become less efficient. TGF-β/SMAD signaling, one of the major pathways that tells fibroblasts to produce collagen, decreases, while oxidative stress activates AP-1 and MMPs, which both suppress new collagen production and increase breakdown of existing collagen. Fragmented collagen also provides less mechanical tension to fibroblasts, further reducing TGF-β signaling and collagen synthesis, creating a self-perpetuating cycle.

As fibroblasts age, the systems they use to repair and maintain themselves become less efficient. DNA damage, dysfunctional mitochondria, impaired autophagy and lysosomal function, telomere shortening, and epigenetic changes begin to accumulate. Eventually, some fibroblasts become so damaged that they enter cellular senescence and can no longer function like healthy younger fibroblasts.

Mitochondria produce the energy fibroblasts need to maintain and repair the dermal extracellular matrix, make collagen, and repair DNA.. Aging mitochondria can become less efficient at producing ATP while generating abnormal levels of reactive oxygen species (ROS). Mitochondrial DNA and membranes can also become damaged. This combination of reduced energy production and increased cellular stress can impair fibroblast function and promote inflammation and cellular senescence.

Proteostasis means maintaining a healthy population of properly made, folded, and functioning proteins. Fibroblasts continually manufacture, fold, repair, and degrade proteins. Aging disrupts this quality-control system, allowing oxidized, misfolded, cross-linked, and otherwise damaged proteins to accumulate. Autophagy, lysosomes, molecular chaperones, and the proteasome all participate in proteostasis, making these aging processes closely interconnected.

Fibroblasts constantly assess nutrients, energy availability, and growth signals to decide whether to grow and synthesize proteins or conserve resources and perform cellular maintenance. mTOR is one of the central regulators of this decision. Persistent or inappropriate mTOR signaling with aging may favor growth-related processes at the expense of autophagy and cellular maintenance. Temporarily modifying this signaling is one approach being investigated as a way to improve cellular resilience and longevity.

These mechanisms do not occur independently. Mitochondrial dysfunction increases oxidative stress, oxidative stress damages DNA and proteins, impaired autophagy and lysosomal function allow damaged material to accumulate, and persistent cellular damage can push fibroblasts toward senescence. Senescent fibroblasts can then release SASP factors that increase inflammation and extracellular-matrix degradation, creating a cycle that further accelerates skin aging.
The goal of a fibroblast “reset” is to interrupt this cycle by improving cellular maintenance, repair, and homeostasis so fibroblasts remain functional longer and are better able to respond when subsequently stimulated.

There is no single way to rejuvenate fibroblasts. The goal is to help stressed fibroblasts function better, prevent or delay cellular senescence, and reduce the burden or harmful effects of cells that have already become senescent. Many longevity pathways and cellular processes are being investigated to find the holy grail of antiaging cosmeceuticals. There is no one best antiaging serum yet. Each serum targets different aging pathways. 

The emerging idea behind a "fibroblast reset" is therefore not simply to stimulate fibroblasts to make more collagen. It is to improve the cellular environment, support repair and housekeeping, reduce senescent-cell burden, and help healthy fibroblasts remain functional longer. The hope is that healthier, better-functioning fibroblasts will ultimately be better able to respond when we ask them to produce collagen and maintain the skin's extracellular matrix.

One approach is targeting mTORC1. Persistent or dysregulated mTORC1 signaling can favor growth and protein synthesis over cellular maintenance and contribute to cellular senescence. Temporarily reducing mTORC1 activity may give stressed fibroblasts a period of “rest,” promote cellular housekeeping processes such as autophagy, and help preserve healthier cellular function.

Another approach is to increase autophagy, the cellular recycling process that helps clear damaged proteins and organelles and lower the number of senescent cells.  Autophagy and normal lysosomal function are important for preventing damaged cellular material from accumulating.

SIRT1 activation is another longevity pathway associated with autophagy and cellular stress resistance. Resveratrol is one skincare ingredient known to activate SIRT1.

Skincare can help aging fibroblasts in two main ways: stimulating them and protecting them from further damage.

Retinoids activate RAR receptors and signal fibroblasts to make more collagen, while L-ascorbic acid (vitamin C) is necessary for normal collagen formation. Growth factors and certain peptides can also stimulate fibroblasts to produce collagen and other extracellular-matrix components. These are common strategies used by the best antiwrinkle serums.

Newer skin-longevity approaches focus on fibroblast health. Ingredients that support autophagy, mitochondrial and lysosomal function, DNA repair, and protection from cellular senescence may help reset fibroblasts and improve how well they function. Sunscreen and antioxidants also help by protecting fibroblasts from further UV and free-radical damage.

New developments in skin longevity are shifting attention from simply stimulating collagen to improving the health and function of tired or exhausted skin cells. Strategies that target cellular senescence, autophagy, mitochondrial and lysosomal function, and pathways such as mTORC1 may help rejuvenate aging fibroblasts and keep healthy fibroblasts functioning longer. This represents one of the newest directions in anti-aging serum research, with the ultimate goal of helping prevent and improve wrinkles, sagging, and thinning skin. The science is exciting and constantly being updated. Many of these antiaging strategies are still new, and we need more clinical studies to determine which approaches truly translate into younger-looking skin.

[[ctaquiz]]

1. Baumann L. Basic Science of the Dermis in Ch. 2 of Baumann's Cosmetic Dermatology Ed 3. (McGraw Hill 2022)
2. Baumann L. Antiaging Ingredients in Ch. 32 of Baumann's Cosmetic Dermatology Ed 3. (McGraw Hill 2022)
3. Kucheryavenko, O., Nelson, G., von Zglinicki, T., Korolchuk, V. I., & Carroll, B. (2019). The mTORC1-autophagy pathway is a target for senescent cell elimination. Biogerontology, 20(3), 331-335.
4. Smith, P., & Carroll, B. (2025). Senescence in the ageing skin: a new focus on m TORC 1 and the lysosome. The FEBS Journal, 292(5), 960-975.
5. Carroll, B., Nelson, G., Rabanal-Ruiz, Y., Kucheryavenko, O., Dunhill-Turner, N. A., Chesterman, C. C., ... & Korolchuk, V. I. (2017). Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing. Journal of Cell Biology, 216(7), 1949-1957.
6. Carosi, J. M., Fourrier, C., Bensalem, J., & Sargeant, T. J. (2022). The mTOR–lysosome axis at the centre of ageing. FEBS Open Bio, 12(4), 739-757.
7. Jin, S., Li, K., Zong, X., Eun, S., Morimoto, N., & Guo, S. (2023). Hallmarks of skin aging: update. Aging and disease, 14(6), 2167.
8. Ho, C. Y., & Dreesen, O. (2021). Faces of cellular senescence in skin aging. Mechanisms of ageing and development, 198, 111525.
9. Walters, H. E., Deneka-Hannemann, S., & Cox, L. S. (2016). Reversal of phenotypes of cellular senescence by pan-mTOR inhibition. Aging (Albany NY), 8(2), 231.